XML 57 R45.htm IDEA: XBRL DOCUMENT v3.22.4
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2022
Share-based Payment Arrangement [Abstract]  
Schedule of stock-based compensation expense
   For the years ended December 31, 
(dollars in thousands)  2022   2021   2020 
Stock option expense  $927    1,148    1,017 
Restricted stock grant expense   1,099    499    380 
Total stock-based compensation expense  $2,026    1,647    1,397 

 

Schedule of the status of the stock option plan and changes
   For the years ended December 31, 
   2022   2021   2020 
           Weighted           Weighted           Weighted 
       Weighted   Average       Weighted   Average       Weighted   Average 
       average   Remaining       average   Remaining       average   Remaining 
       exercise   Contractual       exercise   Contractual       exercise   Contractual 
   Shares   price   Life   Shares   price   Life   Shares   price   Life 
Outstanding at beginning of year   464,724   $33.97         495,195   $29.93         541,414   $26.65      
Granted   
-
    
-
         121,000    40.45         101,700    37.77      
Exercised   (32,375)   27.94         (127,871)   23.56         (93,870)   14.79      
Forfeited or expired   (5,125)   43.14         (23,600)   38.88         (54,049)   38.15      
Outstanding at end of year   427,224   $34.32    5.7 years    464,724   $33.97    6.6 years    495,195   $29.93    6.4 years 
Options exercisable at year-end   287,902   $32.35    4.8 years    239,340   $29.68    5.0 years    287,548   $24.93    5.0 years 
Weighted average fair value of options granted during the year       $
-
             $16.40             $11.37      
Shares available for grant   370,824              422,550              136,339           

  

Schedule of assumptions used
   2022   2021   2020 
Dividend yield   n/a    
-
    
-
 
Expected life   n/a    7 years    7 years 
Expected volatility   n/a    38.48%   25.51%
Risk-free interest rate   n/a    0.74%   1.29%

 

Schedule of the status of the company's non vested restricted stock and changes
   December 31, 
   2022   2021   2020 
   Restricted
Shares
   Weighted
Average
Grant-Date
Fair Value
   Restricted
Shares
   Weighted
Average
Grant-Date
Fair Value
   Restricted
Shares
   Weighted
Average
Grant-Date
Fair Value
 
Nonvested at beginning of year   41,699   $44.71    26,099   $38.05    32,825   $34.78 
Granted   53,376    56.25    26,450    48.56    13,200    39.87 
Vested   (14,213)   43.26    (9,600)   38.03    (14,051)   32.06 
Forfeited   (525)   61.14    (1,250)   38.56    (5,875)   37.74 
Nonvested at end of year   80,337   $52.53    41,699   $44.71    26,099   $38.05